Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT00560443Phase 4Completed
Phase 4, randomised, double-blind trial of tramadol in pain (2 arms), sponsored by IRCCS Burlo Garofolo. Primary endpoint: Estimation of pain reduction at 6 hours. Started Feb 2008; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT00560443.